Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 1,554 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $11.09, for a total transaction of $17,233.86. Following the completion of the sale, the chief operating officer owned 361,085 shares of the company's stock, valued at approximately $4,004,432.65. This represents a 0.43% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Arteris Stock Performance
Shares of AIP stock traded up $2.60 during midday trading on Monday, hitting $13.58. 4,397,458 shares of the company were exchanged, compared to its average volume of 565,523. The firm's 50 day moving average price is $9.65 and its two-hundred day moving average price is $8.43. The firm has a market capitalization of $579.19 million, a P/E ratio of -16.56 and a beta of 1.45. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.58.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The business had revenue of $16.50 million during the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts expect that Arteris, Inc. will post -0.73 EPS for the current year.
Analyst Ratings Changes
Several brokerages have issued reports on AIP. Weiss Ratings reiterated a "sell (d-)" rating on shares of Arteris in a report on Saturday, September 27th. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research report on Monday, September 15th. Finally, TD Cowen boosted their price objective on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $15.00.
Get Our Latest Report on AIP
Hedge Funds Weigh In On Arteris
Several institutional investors and hedge funds have recently added to or reduced their stakes in AIP. Raymond James Financial Inc. bought a new stake in Arteris in the second quarter worth $32,000. CWM LLC lifted its position in Arteris by 4,810.1% during the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after purchasing an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in Arteris in the 1st quarter worth approximately $95,000. Savant Capital LLC bought a new position in Arteris in the 2nd quarter worth $97,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Arteris during the second quarter valued at approximately $104,000. Hedge funds and other institutional investors own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.